Latest news with #www.businesswire.com
Associated Press
4 days ago
- Health
- Associated Press
FPT Proposes Public-Private Partnership Model to Develop Vietnam's Digital Healthcare Ecosystem
HANOI, Vietnam--(BUSINESS WIRE)--Jun 6, 2025-- Global IT services provider FPT and Pharma Group jointly hosted the Healthcare Innovation Forum - HIF 2025. The event served as a multi-stakeholder dialogue platform with a spotlight on breakthrough innovations in science, technology, and AI to accelerate healthcare advancements and drive digital transformation in public health services. This press release features multimedia. View the full release here: FPT Proposes Public-Private Partnership Model to Develop Vietnam's Digital Healthcare Ecosystem The Forum was attended by Vietnam Deputy PM H.E. Le Thanh Long, key government officials, and international guests including U.S. Ambassador Marc Knapper, Swiss Ambassador Thomas Gass, former German Vice Chancellor Dr. Philipp Rösler, and representatives from Japan, Singapore, and Harvard Medical School. Vietnam Deputy PM H.E. Le Thanh Long stressed the urgent need to reform healthcare, outlining five strategies: accelerate digitalization with AI and IoT; boost biotech research; strengthen the pharmaceutical sector; foster public–private partnerships; and expand international cooperation for a modern digital health system. Mr. Darrell Oh, Chairman of Pharma Group, said: 'Pharma Group, representing the innovative pharmaceutical industry, reaffirms its commitment to supporting Vietnam in achieving the goals outlined in Vision 2045. Realizing this ambition requires a unified, multi-stakeholder approach. Only through sustained collaboration can policy be translated into impactful, lasting improvements in public health. Investing in healthcare is, ultimately, an investment in Vietnam's most vital asset: its people.' Dr. Truong Gia Binh, FPT Chairman, stated: 'To accompany Vietnam's new era of advancement, the healthcare sector must achieve breakthroughs in three areas: regulation, innovation, and public–private collaboration. We must shift from restrictive thinking to viewing regulation as a driver of national competitiveness, ensuring faster access to new medicines, like in the U.S. or Japan. Vietnam can become a hub for AI-powered clinical trials and drug development, leveraging its strong tech talent with 1 million IT workers, aiming for half to be AI-proficient. Public–private partnerships must connect hospitals, pharmaceutical firms, and healthcare professionals through shared data platforms. Just as Vietnam rose to global prominence in software, it can now aim to lead in innovative pharmaceuticals - one of the world's most advanced industries.' AI in Pharma: A Global Trend and an Opportunity for Vietnam Recent data shows 80% of pharma professionals use AI for drug discovery, with 95% of companies investing in it; and AI can cut drug development time from 5-6 years to one. In clinical trials, AI can reduce costs by 70% and timelines by 80%. Mr. Hoang Viet Anh, FPT Digital Chairman and FPT Telecom Chairman, FPT Corporation, underscored: 'AI and GenAI are transforming the pharmaceutical industry, with key benefits including accelerating new drug development and enhancing clinical trials across the value chain.' He also called this a key moment for digital transformation, outlining an AI roadmap for Vietnam's pharmaceutical sector through 2028. Plans include a centralized data system and AI lab pilots in 2025, blockchain trials in 2026 to fight counterfeit drugs, and a 20% reduction in drug trial time by 2027, aiming to become ASEAN's leading AI hub by 2028. Achieving Resolution 57 and National Goals for Healthcare Breakthroughs As Vietnam pursues its 2045 high-income vision, healthcare emerges as a key pillar for quality of life, social security, and sustainable growth. The round table discussing critical factors to achieve Resolution 57 objectives emphasized three key messages. Firstly, AI and big data drive healthcare innovation, enabling faster drug development and personalized care. Secondly, bold legal and institutional reforms are essential to match tech advances, including streamlined approvals and flexible data regulations. Lastly, strong public-private collaboration is vital to build a sustainable innovation ecosystem connecting tech firms, hospitals, research institutes, and startups. Mr. Vu Anh Tu, FPT Chief Technology Officer, commented: 'AI is set to transform healthcare, and by creating a centralized health data infrastructure and leveraging AI and data analysis for new drug trials, Vietnam can establish advanced clinical research centers, shorten timelines, reduce costs, and expand public access to new medicines. Technology can also enable new healthcare delivery models like telemedicine hospitals to improve primary healthcare and expand public access.' He further stated: 'FPT is ready to collaborate with startups, major enterprises, and global AI research institutions to address key challenges through AI. This approach will mobilize domestic and international resources to drive breakthroughs in this new era.' About Pharma Group Founded in 1998, Pharma Group represents the innovative pharmaceutical industry in Vietnam, comprising 20 member companies from Europe, the United States, and Japan. These companies share a mission to ensure timely and sustainable access to high-quality, safe, and innovative medicines for Vietnamese patients. Pharma Group operates under the European Chamber of Commerce in Vietnam (EuroCham) and is a member of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). It works closely with policymakers and healthcare stakeholders in Vietnam and globally to advance sustainable health policies and initiatives, reduce the time to patient access, and build a favorable and attractive investment environment. About FPT Corporation FPT Corporation is Vietnam's leading technology group, pioneering digital transformation and leading in technology and telecommunications solutions and services. FPT supports clients in over 30 countries and territories in achieving their business development strategies through technology. In the healthcare sector, FPT is committed to building a remote healthcare platform and a comprehensive digital medical ecosystem that delivers fast, convenient, and integrated services for regulators, medical institutions, pharmaceutical companies, pharmacy networks, and the public. Leveraging over a decade of AI research and development, FPT actively integrates AI technologies to enhance healthcare quality and expand access to personalized medical services, particularly through telemedicine and real-time patient health monitoring. In pharmaceuticals, FPT advances the sector by digitizing R&D processes, deploying Advanced Pharmacy Omni-Channel Systems, and developing comprehensive drug management platforms connecting patients, doctors, and pharmacies through electronic medical records. Prominent clients include Long Chau Pharmacy, Hitachi Medical Devices, Olympus, MedAdvisor, Zuellig Pharma, and BrightInsight. View source version on CONTACT: Media Contact Mai Duong (Ms.) FPT Corporation FPT Software PR Manager [email protected] KEYWORD: VIET NAM SOUTHEAST ASIA ASIA PACIFIC INDUSTRY KEYWORD: TECHNOLOGY CLINICAL TRIALS HEALTH TECHNOLOGY TELEMEDICINE/VIRTUAL MEDICINE SOFTWARE HEALTH PHARMACEUTICAL DATA MANAGEMENT ARTIFICIAL INTELLIGENCE SOURCE: FPT Corporation Copyright Business Wire 2025. PUB: 06/06/2025 07:13 AM/DISC: 06/06/2025 07:12 AM
Associated Press
6 days ago
- Business
- Associated Press
Quantum Health Signs Agreement to Acquire Embold Health
DUBLIN, Ohio & NASHVILLE, Tenn.--(BUSINESS WIRE)--Jun 4, 2025-- Quantum Health ('Quantum'), the creator of healthcare navigation, has signed a definitive agreement to acquire Embold Health ('Embold'), a leading physician-led healthcare technology company. The transaction is expected to close within the next 14 days, subject to customary closing conditions and regulatory approvals. This press release features multimedia. View the full release here: This strategic move deepens Quantum's investment in AI-powered personalization, significantly enhancing its Real-Time Intercept ® (RTI) and provider engagement capabilities to guide members to cost-effective, high-quality care while driving ROI for clients. Together, Quantum and Embold will offer an expanded portfolio of products to the market. 'By joining forces, we're not just adding technology — we're elevating the standard for healthcare navigation,' said Dayne Williams, CEO of Quantum. 'Our Healthcare Warriors ®, already known for their compassion and expertise, will be equipped with even more powerful tools to guide members to the best care. When you combine our high provider and member Net Promoter Scores ® (NPS) with Embold's AI, you get a complete, intelligent and human-centered navigation experience built to deliver ROI.' The acquisition builds on a strong existing partnership between the two organizations. By pairing Embold's proven provider quality analytics and conversational AI capabilities with Quantum's 26-year legacy of navigation expertise and unparalleled provider relationships, the combined entity is well-positioned to redefine the way consumers engage with healthcare. Embold will continue to operate as an independent entity, upholding its commitment to delivering exceptional service to its clients. With enhanced investment and resources from Quantum, Embold will accelerate the advancement of its product roadmap, further strengthening its ability to serve clients with innovative, data-driven solutions. 'This is about bringing together two companies with shared missions,' said Dr. Daniel Stein, CEO and Founder of Embold, who will now serve as President of Embold. 'Together, we remain focused on delivering the trusted insights our clients count on, with enhanced capabilities to help even more members access higher-quality care.' Integrating with Embold's proprietary physician-level analytics and AI-powered provider recommendation engine, Quantum will deliver the most complete navigation experience in the industry — one that balances trust, quality and action. The combined company will serve more than 8 million members nationwide, increasing the scale and scope of its products and capabilities. Raymond James & Associates, Inc. served as financial advisor, and Mayer Brown LLP served as legal counsel to Embold Health, while Kirkland & Ellis LLP served as legal counsel to Quantum. About Quantum Health Quantum Health is the industry-leading consumer healthcare navigation and care coordination company that delivers an unparalleled consumer experience to its members, as well as validated claims savings and high satisfaction rates for its self-insured employer and payer clients. Quantum Health's proprietary Real-Time Intercept® capability identifies opportunities for early intervention in a member's healthcare journey, resulting in better engagement, outcomes and cost efficiencies. Founded in 1999 and based in Dublin, Ohio, Quantum Health has earned numerous awards and honors, including being named among the Fastest-Growing Private Companies by Inc. 5000, a Great Place to Work by FORTUNE Magazine and Entrepreneur Magazine, and one of FORTUNE'S Best Workplaces in Healthcare. The Women Presidents' Organization has also ranked Quantum Health as one of the 50 Fastest-Growing Women-Owned/Led Companies for over 15 years. To learn more about the company, visit and connect with us on LinkedIn and X. About Embold Health Embold Health, a healthcare technology company, helps employers and health plans improve outcomes and lower costs by empowering members to make informed healthcare decisions. Evaluating 21 specialties and 68 sub-specialties, Embold's patented and peer-reviewed provider quality score methodology analyzes data from 230+ million individuals across the entire care journey at the individual physician performance level. Setting the standard for responsible AI in healthcare, Embold's conversational AI simplifies the care-seeking process. Paving the way for more efficient, personalized, and cost-effective care, Embold is transforming how care is sought out and delivered. To learn more, visit Disclaimer This announcement contains forward-looking statements, which are subject to risks and uncertainties. These statements include, but are not limited to, expectations regarding the completion and timing of the proposed acquisition. Actual results may differ materially due to various factors, including the satisfaction of closing conditions and other unforeseen developments. View source version on CONTACT: Media Contact Alison Travis Corporate Communications Manager [email protected] 220-465-9386 KEYWORD: TENNESSEE OHIO UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: TECHNOLOGY HEALTH TECHNOLOGY PROFESSIONAL SERVICES SOFTWARE PRACTICE MANAGEMENT GENERAL HEALTH DATA ANALYTICS HEALTH DATA MANAGEMENT ARTIFICIAL INTELLIGENCE SOURCE: Quantum Health Copyright Business Wire 2025. PUB: 06/04/2025 08:15 AM/DISC: 06/04/2025 08:15 AM
Globe and Mail
16-04-2025
- Business
- Globe and Mail
Komaspec Expands to Mexico With New Factory for Custom Metal Part Manufacturing
Due to the increasing demand for high-quality custom metal components, Komaspec, a Canadian-owned contract manufacturer, has added its newest manufacturing facility in Mexico, adding 20,000 square feet to its global production network and the option to price and produce parts in both Mexico and China. This expansion is a key milestone in serving the North American market with reduced lead times and enhanced manufacturing efficiency. This press release features multimedia. View the full release here: Inside Komacut's Mexico facility, featuring advanced machinery and optimized production zones for efficient custom metal part manufacturing. The custom metal parts produced in this facility are available exclusively through Komaspec's on-demand digital platform for sheet metal fabrication. Customers can access instant online quotations, seamless ordering, and fast delivery for high-precision metal parts directly from the Mexico-based factory. Located in a free trade zone, the facility is equipped with state-of-the-art manufacturing technology to support a range of custom sheet metal fabrication capabilities, including: Laser Cutting – High-speed, precise metal cutting Sheet Metal Bending – Complex bending and forming with tight tolerances Threading & Chamfering – Enhanced component functionality Surface Finishing – Custom coatings for durability and aesthetics Laser Engraving – Permanent part marking for branding and traceability By manufacturing in Mexico, Komaspec significantly reduces shipping times for customers in the United States, Canada, and Latin America. Through businesses can instantly quote, order, and receive custom metal parts with a seamless digital experience. The platform provides instant, transparent pricing, DFM (Design for Manufacturing) feedback, and fast production, ensuring efficiency, quality, and scalability for OEMs, small businesses and big brands. In 2024, Komacut produced hundreds of thousands of high-precision parts for customers worldwide. As part of its long-term strategy, the company continues to invest in automation, digital manufacturing, and vertically integrated operations, reinforcing its commitment to providing premium-quality custom parts at scale. About Komaspec & Komacut Founded in 2005, Komaspec is a full-service contract manufacturer, specializing in custom sheet metal fabrication, electro-mechanical assemblies, and turnkey production solutions. With facilities in China and Mexico, Komaspec enables businesses to innovate faster through advanced manufacturing technologies and digital ordering capabilities. Komacut is Komaspec's business-facing, on-demand metal fabrication platform, allowing customers to instantly quote and order custom sheet metal and machined parts online. With fast production, transparent pricing, and global logistics support, Komacut streamlines the manufacturing process from design to delivery.
